<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>RE Mujica Mota | Tristan Snowsill</title>
    <link>https://www.tristansnowsill.co.uk/author/re-mujica-mota/</link>
      <atom:link href="https://www.tristansnowsill.co.uk/author/re-mujica-mota/index.xml" rel="self" type="application/rss+xml" />
    <description>RE Mujica Mota</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>© 2020 Tristan Snowsill</copyright><lastBuildDate>Wed, 01 Mar 2017 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://www.tristansnowsill.co.uk/images/icon_hu050d7ab96a8b87ebb29a3f4b58eca100_52805_512x512_fill_lanczos_center_2.png</url>
      <title>RE Mujica Mota</title>
      <link>https://www.tristansnowsill.co.uk/author/re-mujica-mota/</link>
    </image>
    
    <item>
      <title>Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal</title>
      <link>https://www.tristansnowsill.co.uk/publication/tikhonova-2017-azacitidine-for-treating-acute-myeloid-leukaemia/</link>
      <pubDate>Wed, 01 Mar 2017 00:00:00 +0000</pubDate>
      <guid>https://www.tristansnowsill.co.uk/publication/tikhonova-2017-azacitidine-for-treating-acute-myeloid-leukaemia/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
